The breath test, which is administered by health care providers, can provide results in under three minutes.
The U.S. Food and Drug Administration authorized the first breathalyzer test to detect COVID-19.that it was issuing an emergency use authorization for the InspectIR COVID-19 Breathalyzer, which detects coronavirus infections through breath samples. The test can provide results in under three minutes.
“Today’s authorization is yet another example of the rapid innovation occurring with diagnostic tests for COVID-19,” Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a release from the agency. He noted that this innovation could help with the current pandemic and “better position the U.S. for the next public health emergency.”
In a study of over 2,000 people, the test was found to have 91.2% sensitivity and 99.3% specificity . Clinical, but the device was also tested specifically on the omicron variant, the FDA said. Health care providers can use the test, which is about the size of carry-on luggage, on patients in doctor’s offices, hospitals and mobile testing sites, according to the FDA.of the coronavirus has been spreading in the U.S., cases nationwide have begun to tick back up. Case levels are still currently far lower than they were during the major winter spike. Vaccination remains the best method of protection against hospitalization and death from the virus.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA authorizes first Covid-19 breath testThe agency granted emergency use authorization for the test, which detects chemical compounds in breath samples. A positive result should be confirmed with a molecular test.
Read more »
Unemployment claims on the rise (but still remain low), FDA authorizes COVID breath test, and more COVID newsJobless claims rose by 18,000 to 185,000, the Labor Department said Thursday, after nearly touching the lowest level since 1968 in the previous week. Here's that and more COVID-19 news.
Read more »
FDA Wants More Diversity in Clinical Trials
Read more »
McKinsey consulted on opioids for the FDA — and also with opioid makers, report claimsThe committee's chairwoman Carolyn Maloney called McKinsey's actions 'egregious' and said the company needs to answer for its actions.
Read more »
Ferrero recalling Kinder chocolates just before Easter, FDA saysFerrero recalling some Kinder chocolates just before Easter, the FDA says
Read more »
E-cigs using synthetic nicotine come under FDA oversightUnder a law taking effect Thursday, the Food and Drug Administration can regulate e-cigarettes and similar products that use synthetic nicotine.
Read more »